Wealth Effects’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Wealth Effects's PFE Position: Q1 2026 in Review
Wealth Effects increased its Pfizer (PFE) stake by 5.5% in Q1 2026, buying an estimated $105K and bringing the position to 76,075 shares worth $2.14M. The position accounts for 0.76% of the portfolio, ranked #27.
Wealth Effects first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.1M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wealth Effects held 76,075 shares of Pfizer worth $2.14M as of Q1 2026.
- Wealth Effects bought 3,959 Pfizer shares in Q1 2026, an estimated $105K.
- Pfizer made up 0.76% of Wealth Effects's portfolio in Q1 2026, its #27 holding.
- Wealth Effects first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Wealth Effects's Pfizer position peaked at $4.1M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.